InvestorsHub Logo
Followers 277
Posts 33436
Boards Moderated 1
Alias Born 11/14/2013

Re: PacificNW post# 8386

Wednesday, 04/09/2014 5:07:27 AM

Wednesday, April 09, 2014 5:07:27 AM

Post# of 723401
Afford,

Anything is possible, but the evidence is becoming quite compelling toward these agents for all three programs. Please look at the very informative and digestible article written by Marnix Bosch and company in 2003, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC239912/ , and trace that into NWBO's October 2012 patent application, http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=17&f=G&l=50&co1=AND&d=PG01&s1=northwest&s2=biotherapeutics&OS=northwest+AND+biotherapeutics&RS=northwest+AND+biotherapeutics ,and compare that with the 2008 10K
recently referenced, followed by the 2013 PATENT awarded regarding "Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines," http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PTXT&s1=northwest&s2=biotherapeutics&OS=northwest+AND+biotherapeutics&RS=northwest+AND+biotherapeutics.



Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News